Tspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a

Manale El Kharbili1,2, Muriel Cario3,4, Nicolas Béchetoille5

  • 1Centre de Génétique et de Physiologie Moléculaires et Cellulaires, CNRS UMR5534, Université de Lyon, F-69003 Lyon, France.

Cancers
|May 28, 2020
PubMed

Insights

Tetraspanin 8 (Tspan8) promotes melanoma spread by enabling cancer cells to invade the dermis. Targeting Tspan8 with antibodies may block this early stage of skin cancer metastasis.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Melanoma is an aggressive skin cancer with challenging treatments.
  • Early melanoma dissemination involves dermal-epidermal junction (DEJ) degradation and dermal invasion, with underlying mechanisms poorly understood.
  • Tetraspanin 8 (Tspan8) was previously identified as a key factor in melanoma invasiveness.

Purpose of the Study:

  • To elucidate the mechanisms by which Tspan8 drives melanoma dermal invasion.
  • To investigate the role of Tspan8 in melanoma cell interaction with surrounding keratinocytes.
  • To evaluate the therapeutic potential of Tspan8-blocking antibodies against melanoma spread.

Main Methods:

  • Utilized a validated skin-reconstruct model mimicking melanoma dermal penetration through an authentic DEJ.
  • Analyzed Tspan8 expression in melanoma cells and its effect on keratinocyte activation.
  • Assessed levels of matrix metalloproteinase-9 (MMP-9), MMP-3, and tissue inhibitor of metalloproteinase-1 (TIMP-1).
  • Tested the efficacy of a specific Tspan8-blocking antibody in reducing proMMP-9 activation and dermal invasion.

Main Results:

  • Tspan8 expression was sufficient to induce melanoma cell translocation into the dermis.
  • Tspan8-positive melanoma cells promoted keratinocyte-derived proMMP-9 activation, leading to collagen IV degradation and dermal colonization.
  • Elevated active MMP-3 and reduced TIMP-1 levels were observed, favoring MMP-9 activity.
  • A Tspan8-specific antibody significantly reduced proMMP-9 activation and melanoma dermal invasion.

Conclusions:

  • Melanoma cells utilize Tspan8 to cooperatively engage keratinocytes, facilitating invasion via MMP-9 activation and collagen degradation.
  • This study reveals a novel, cell non-autonomous mechanism of melanoma invasion mediated by Tspan8 and keratinocytes.
  • Tspan8-blocking antibodies show promise for impeding early melanoma spread and preventing metastasis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K